Format

Send to

Choose Destination
Viral Immunol. 2014 Jun;27(5):245-9. doi: 10.1089/vim.2013.0119. Epub 2014 May 5.

Polymorphism of DC-SIGN (CD209) promoter in association with clinical symptoms of dengue fever.

Author information

1
1 Human and Medical Genetics, Federal University of Pará , Belém, Pará, Brazil .

Abstract

C-type lectin DC-SIGN receptor, encoded by CD209, plays a key role in the infection of dendritic cells by dengue virus (DENV). Because the -336A/G SNP (rs4804803) polymorphism in the promoter of CD209 modulates DC-SIGN expression, we investigated the putative association of this polymorphism with DENV infection and its pathogenesis. A control sample of 72 individuals, rigorously selected through a clinical investigation for absence of past dengue fever (DF) was compared to a sample of 168 patients (156 classical DF; 12 dengue hemorrhagic fever), all residents from Pará, Brazil. However, the prevalence of symptoms showed a trend higher in the AA genotype (Wilcoxon test; Z=2.02; p=0.04). Hence, our findings indicate that the G allele downregulates the spectrum of symptoms during the early acute phase of DENV infection, putatively decreasing the viremia, as suggested in the literature.

PMID:
24797508
DOI:
10.1089/vim.2013.0119
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Mary Ann Liebert, Inc.
Loading ...
Support Center